Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2a study of M520102 in atopic dermatitis
jRCT2080221901Phase 2
- Sponsor
- Maruho Co., Ltd.
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ATI-1777 in atopic dermatitis (AD) (3 arms), sponsored by Maruho Co., Ltd.
02
Drugs
ATI-1777
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on jRCT2080221901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221901.